R&D Commitment Hero Image

The lifeblood of health is research and discovery (R&D). That’s why America’s Biopharmaceutical Companies recently announced a bold new commitment to the R&D of new treatments and cures for patients


LATEST ARTICLES


RELATED ARTICLES

World IP Day image

How Intellectual Property Protections Spur Innovation

Strong IP protections are critical to safeguarding innovation within the biopharmaceutical industry. 

AI Thumbnail

Speeding Innovation with AI and Big Data

Biopharmaceutical researchers are using AI to cut the time and costs it takes to manually sift through datasets.
 

New Era For Mental Health Thumbnail

A New Era for Mental Health

Learn about the 138 medicines in development to treat mental illnesses.

3 Innovations Thumbnail

3 Groundbreaking Innovations That Were First Approved in the United States

Breakthrough therapies are approved in America quickly, and this translates to hope for patients and families.

US Capitol Building

Why Washington Shouldn't Copy the Flawed Pricing Policies of Other Countries

America is the world's leading source of innovation. Let's keep it that way.

Marie-Claire Peakman Thumbnail

Researcher Profile: Dr. Marie-Claire Peakman

Dr. Marie-Claire Peakman always knew she wanted to make a difference in the world.

A New Personalized Cancer Treatment Thumbnail

A New Personalized Cancer Treatment Shows What’s Possible in the New Era of Medicine

In recent years, researchers have expanded the limits of science so quickly that methods of treatment thought to be impossible a decade ago are now a reality.
 

Researcher Profile: Andrea Fanjul

Researcher Profile: Andrea Fanjul

For Dr. Andrea Fanjul and a team of scientists at Takeda, it’s the patients and their stories that bring purpose to their work.

Your Epilepsy Does Not Define You image

Your Epilepsy Does Not Define You

Epilepsy patient, caregiver and advocate Loretta Boileau has seen firsthand the benefits of innovative treatments for her and her family, but knows there is still a long road ahead.

Researcher Profile: Henrik Klitgaard image

Researcher Profile: Henrik Klitgaard

With nearly 30 years of experience in biopharmaceutical research, Dr. Henrik Klitgaard has dedicated his life to pursuing new and better treatments for patients with epilepsy.

Pursuing Novel and Targeted Treatments for Epilepsy image

Pursuing Novel and Targeted Treatments for Epilepsy

Epilepsy is a complex condition, and it will take an equally complex approach to put an end to the disease. America's biopharmaceutical companies will not be satisfied until that goal is reached.

Researcher Profile: Niranjana Nagarajan image

Researcher Profile: Niranjana Nagarajan

According to Dr. Niranjana Nagarajan, a principal scientist at Celgene, "sheer curiosity" drove her into biopharmaceutical research.

HUBweek2018: Why Innovation Needs Cross-Sector Collaboration image

HUBweek 2018: Why Innovation Needs Cross-Sector Collaboration

Innovation does not happen in a vacuum. Instead, it requires a rich ecosystem of talent, capital, expertise and logistics to translate theoretical science into life-saving treatments and therapies.

Getting Ahead of Migraines image

Getting Ahead of Migraines

Understanding migraines fully can give patients back time taken by the disease.

Clinical Trials The Key to Innovative New Medicines image

Clinical Trials: The Key to Innovative New Medicines

Learn more about the importance of clinical trials to the biopharmaceutical innovation process.

Recognizing Diversity in Clinical Trials image

Recognizing Diversity in Clinical Trials

Every time you take a medicine – even if it's just for a headache – you are benefitting from the results of a clinical trial.

Researcher Profile: Paul Nioi image

Researcher Profile: Paul Nioi

Paul is a scientist in the Research and Development Group at Amgen where he is focused largely on the development of novel approaches for evaluating potential new medicines using genetics, including recent scientific breakthroughs in heart disease.

Researcher Profile: Matthew Kennedy image

Researcher Profile: Matthew Kennedy

Matt has spent the majority of his nearly 20-year career in drug discovery searching for a cure to one of the most challenging diseases, Alzheimer's.

Researcher Profile: Pablo Sardi image

Researcher Profile: Pablo Sardi

Dr. Pablo Sardi is a Research and Development director in the Neurobiology Unit at Sanofi. He started his career in Boston doing post-doctoral research at Harvard and moved to Genzyme in 2007 to pursue his interest in investigating disease mechanism to develop therapies to treat neurodegenerative diseases.

Florida Clinical Trials image

Florida Clinical Trials

Recently, America's biopharmaceutical companies joined the American Cancer Society for the Cancer Action Network Clinical Trials Policy Forum at the Mayo Clinic in Jacksonville, Florida.

A Pipeline of Promise: Immuno-oncology image

A Pipeline of Promise: Immuno-oncology

We are in a new era of medicine, powered in part by the advancements and innovations being made in the field of immuno-oncology or immunotherapy

What's Next? Discovery, Treatments and Cures in the Biopharmaceutical Pipeline image

What's Next? Discovery, Treatments and Cures in the Biopharmaceutical Pipeline

For many patients, the biopharmaceutical pipeline is their best hope for a cure or a longer, healthier life.

Researcher Profile: Christina Trout image

Researcher Profile: Christina Trout

Christina works in the Epigenetic Department at Celgene as a research scientist, exploring a number of cancer indications.

The Power of Partnership in Genomic Medicine image

The Power of Partnership in Genomic Medicine

Leading minds were recently brought together from the biopharmaceutical industry to research organizations continuing the dialogue series around The New Era of Medicine.

A New World of Medicine image

A New World of Medicine

Join us on a journey deep into the new frontier of medicine. Explore how immunotherapy can take the place of chemotherapy and how medicines once made for the masses are now designed specifically for you.

The Next Generation of Research image

The Next Generation of Research

Industry leaders came together for "Sequencing the Genome: Examining Modern Medicine," a conversation focused on leading scientific minds and the breakthrough treatments they’re working to advance.

No Stone Unturned in Mental Health Research image

No Stone Unturned in Mental Health Research

Treating patients with mental health disorders is about getting to know the person behind the disease. More than any other branch of medicine, psychiatry involves putting a little bit of yourself into your work, and forming a bond with your patient.

The New Era of Medicine with Stephen Ubl image

The New Era of Medicine with Stephen Ubl

We are in a new era of medicine where innovations are transforming our ability to attack the cause o…

Brain Awareness Week image

Brain Awareness Week

For all we have accomplished in neuroscience, our understanding of human brain function and the diseases that affect it remains a tremendous challenge for researchers.

How Medical Technology Is Saving Lives image

How Medical Technology Is Saving Lives

Meet inspiring individuals who were diagnosed with a serious medical condition and learn how advanced medical technology helps them lead healthy lives once again.

Research Doesn’t End on A Medicine’s Approval image

Research Doesn’t End On A Medicine’s Approval

Research on a medicine doesn't end on the initial approval by the FDA. Eli Lilly and Company's chief medical officer shares why ongoing research helps us better understand a medicine's full value.

Cumulative Steps, Big Gains for Patients image

Cumulative Steps, Big Gains for Patients

Advances in treating debilitating diseases are often not the result of one single breakthrough, but rather an accumulation of knowledge and research over time.

Brain Cancer: Research Brings Hope to a Difficult Disease image

Brain Cancer: Research Brings Hope to a Difficult Disease

Between 1998 and 2014, there were 75 unsuccessful drugs and 3 approved drugs for brain cancer.

A Decade of Innovation in Treatment for Multiple Sclerosis (MS) Patients image

A Decade of Innovation in Treatment for Multiple Sclerosis (MS) Patients

Ten years ago, treatments were limited to a handful of medicines. Today, MS patients have more treatment options with fewer side effects.

The American Innovation Engine: Keeping the United States Competitive for Biopharmaceutical Investors image

The American Innovation Engine: Keeping the United States Competitive for Biopharmaceutical Investors

Investment is a key driver of innovation across all industries. However, investment is especially important to the research-intensive biopharmaceutical industry.

Multiple Sclerosis: Then and Now image

Multiple Sclerosis: Then and Now

While there is no cure for multiple sclerosis (MS), a decade of innovation has changed the way we treat the disease and enhance the lifestyles of people living with it.

A New Age of Viral Disease Treatment: The Cure Developed by Biopharmaceutical Companies that Saved a Mother of Six image

A New Age of Viral Disease Treatment: The Cure Developed by Biopharmaceutical Companies that Saved a Mother of Six

Hepatitis C kills more Americans than any other infectious disease. Carleen was one of those affected. She had five children and was pregnant with her sixth when she was diagnosed with the disease.

The Promise of Personalized Medicine image

The Promise of Personalized Medicine

Discover how America's Biopharmaceutical Companies developed groundbreaking weapons to destroy the body's rogue cells.